Snowball logo
logo
  • Stocks
  • China
  • Healthcare
3010

Shanghai Labway Clinical Laboratory Co Ltd

301060 • SHE
¥11.96¥0.00  (0%)
Estimate
P/E
398.7
EPS
0.03
Beta
0.525
Growth
Revenue, YoY
-18.16%
Net income, YoY
556.8%
FCF, YoY
1,062.64%
Dividends
Dividend yield
1.51%
Annual payout
¥0.18
Next ex. div date
June 8, 27
Payout
646.4%
Div.rating
About the company
Ticker
301060
ISIN
CNE100004RG8
Country
China
Sector (GICS)
Healthcare
Shanghai Labway Clinical Laboratory Co., Ltd. engages in the sale of in-vitro diagnostic products in China. The company distributes in-vitro diagnostic instruments, reagents, and related accessories and consumables. It also provides third-party medical testing, pathological diagnosis services, in-vitro diagnostic products, precision medicine, research and technical services, medical data management solutions and professional technical support services. In addition, the company offers leasing, business, and human resources services. The company serves medical and research institutes. Shanghai Labway Clinical Laboratory Co., Ltd. was founded in 1993 and is headquartered in Shanghai, China.

Frequently asked questions

What sector does Shanghai Labway Clinical Laboratory Co Ltd (301060) operate in?

Shanghai Labway Clinical Laboratory Co Ltd belongs to the Healthcare sector and operates in the Diagnostics & Research industry.

What is Shanghai Labway Clinical Laboratory Co Ltd (301060) current stock price?

As of the latest data, Shanghai Labway Clinical Laboratory Co Ltd stock price is CN¥11.96, with a previous close of CN¥11.96.

What is Shanghai Labway Clinical Laboratory Co Ltd (301060) current market capitalization?

Shanghai Labway Clinical Laboratory Co Ltd market cap is approximately 4.79 billion.

What is Shanghai Labway Clinical Laboratory Co Ltd (301060) Earnings Per Share (EPS)?

The trailing EPS is CN¥0.03.

What is Shanghai Labway Clinical Laboratory Co Ltd (301060) Price-to-Earnings (P/E) ratio?

Shanghai Labway Clinical Laboratory Co Ltd current P/E ratio is 398.67.

Does Shanghai Labway Clinical Laboratory Co Ltd (301060) pay dividends?

Yes. Shanghai Labway Clinical Laboratory Co Ltd pays annual dividends with an annualized yield of 1.51% and an estimated annual payout of CN¥0.18 per share.

When is the next ex-dividend date for Shanghai Labway Clinical Laboratory Co Ltd (301060)?

The next ex-dividend date is scheduled for June 08, 2027.

What is Shanghai Labway Clinical Laboratory Co Ltd (301060) beta (volatility) score?

Shanghai Labway Clinical Laboratory Co Ltd has a beta of 0.525, indicating lower volatility than the overall market.
2026 © Snowball Analytics
𝕏
Snowball Analytics SAS914 331 640 R.C.S. LYON
Greffe du tribunal de Commerce de LYONAddress: LE FORUM 27 RUE MAURICE FLANDIN
LYON CEDEX 3, 69444, FranceEmail: [email protected]
Get the Snowball Analytics app
Download Snowball Analytics on App Store
4.8 • 4600ratings
Download Snowball Analytics on Google Play
4.8 • 2500ratings
Powered by EODHD, SnapTrade
ProductPortfolio trackerStock trackerDividend trackerDividend calendarDividend calculatorsSharesight vs. Dividend.Watch vs. Snowball AnalyticsPricing
ResourcesTerms and conditionsPrivacy policySecurityYodleeAbout usContacts
Support Support Knowledge Base
Snowball Analytics would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The site and content, are provided “as is” and without warranties of any kind. You bear all risks associated with the use of the site and content, including without limitation, any reliance on the accuracy, completeness or usefulness of any content available on the site. The Website should not be relied upon as a substitute for extensive independent market research before making your actual trading decisions. Past performance is not an indicator of future performance. Snowball Analytics is not a registered investment advisor or broker/dealer. Any opinions, charts, messages, news, research, analyses, prices, or other information contained on this Website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice.
Interactive Brokers is not affiliated with Snowball Analytics and does not endorse or recommend any information or advice provided by Snowball Analytics.